In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Hugo Geerts Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Hugo
Last Name:Geerts
Title:Scientific Liaison officer
Advanced Degrees:PhD, Bach Med.
Affiliation:In Silico Biosciences
Department:Computational Neuropharmacology
Street Address 1:686 Westwind Drive
City:Berwyn
State/Province:PA
Country/Territory:U.S.A.
Phone:267-679-8090
Email Address: 
Disclosure:
(view policy)  		Member reports the following financial or other potential conflicts of interest: [Last Modified: 26 August 2010]

I am an employee of In Silico Biosciences
View all comments by Hugo Geerts
Clinical Interests:
Alzheimer Disease, Tauopathies
Research Focus:
Brain imaging, Neurotransmission, Tau/Cytoskeleton, Drug screening
Work Sector(s):
Industry
Web Sites:
Professional: www.in-silico-biosciences.com
Researcher Bio
Hugo Geerts is currently Chief Scientific Officer of In Silico Biosciences, a company that provides mechanistic disease modeling services in CNS Drug discovery & Development. After an undergraduate degree in physics (with emphasis on theoretical quantum-mechanics) and a PhD in Biophysics he got a Bachelor Degree in Medicine, a Master in Pharmaceutical Sciences, and a Pharma Executive MBA at the Drexel University in Philadelphia. He worked for 17 years with Dr. Paul Janssen, probably the greatest drug hunter in history at the Janssen Research Foundation (part of J&J) where he was involved in Alzheimer research and supported the succesfull clinical development of galantamine. His is passionate about the need for more integrated modeling & simulation along the whole Drug R&D process to reduce the failure rate of clinical trials and to get better drugs faster to the right patients. He is currently also Adjunct Associate Professor in the School of Medicine at the University of Pennsylvania.
What is the greatest void to date in our knowledge of Alzheimer's Disease?
I think the biggest void is the immensely(large) gap between molecular biochemical processes such as amyloid-beta modulation or tangle formation and the functional cognitive performance of the patient. I am a great fan of bringing the community of cognitive neuroscience togetehr with the community of Alzheimer researchers. As long as we don't get a better insigth on the relation of nejuronal cell pathology to emergent properties of networks, we won't be able to make real progress in treating this disease

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad